Pfizer is investing $120 million to expand its pharmaceutical facility in Michigan, USA. The expansion will increase production of Paxlovid for the treatment of COVID-19.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept